Dr Teresa Bonello was awarded the Cancer Council ACT annual grant earlier this year.

In a field of daffodils, this cancer researcher is standing out

In a field of daffodils, this cancer researcher is standing out

Dr Teresa Bonello was awarded the Cancer Council ACT annual grant earlier this year.

In the vast field of cancer research, where many focus on the obvious—like daffodils standing tall in a bright meadow - meet Dr Teresa Bonello - distinct and dedicated to exploring the often-overlooked yet crucial elements of the tumour microenvironment.

At the John Curtin School of Medical Research (JCSMR) at The Australian National University, Dr Bonello’s work stands out, highlighting how the context around cancer cells, their cellular ecosystem, can dramatically influence cancer’s initiation, progression, and resistance to treatment.

“We now understand that the context in which cancer cells exist has significant consequences for their behaviour and response to treatment,” says Dr Bonello.

Daffodil Day, one of Cancer Council Australia’s most beloved fundraising initiatives, holds special significance for Dr Bonello. “The money supporting this research comes from an inspiring community of people who raise funds for the Australian Cancer Council,” she shares. “I feel honoured that Daffodil Day falls on my birthday this year; it feels like an affirming nod to keep moving forward and digging deeper.”

Dr Teresa Bonello in a lab at JCSMR.

“My goal is to maintain a bidirectional flow of information between the clinic and our work at the lab bench” says Dr Teresa Bonello. Photo: Tracey Nearmy/ANU

A key focus of Dr Bonello’s research is on the oncoproteins YAP and TAZ. “These proteins are commonly activated in tumour cells, but they also play a role in the tumour microenvironment, where they promote malignancy,” she explains.

This research is particularly impactful in addressing triple-negative breast cancer (TNBC), a challenging subtype due to its lack of druggable targets. “The tumour microenvironment is a major determinant of how patients respond to immunotherapy, so modifying it could enhance immunotherapy’s effectiveness,” Dr Bonello adds.

Before joining JCSMR, Dr Bonello was deeply involved in epithelial biology research at the University of North Carolina, Chapel Hill, using Drosophila (fruit flies) as a model. “What many don’t realise is that Drosophila research has led to six Nobel Prizes and pioneered the identification of oncogenes and tumour suppressors in human cancer,” she shares.

This background provided a strong foundation for her move to Australia, where she expanded her research into epithelial organoid and mouse models. JCSMR was the perfect place for this expansion, being one of the few hubs for Drosophila research in Australia. “Being part of this community has been incredibly valuable,” says Dr Bonello. “It’s been vital to connect with exceptional Drosophila researchers at JCSMR and to contribute to training the next generation of researchers.”

The supportive environment at JCSMR has been instrumental in her success. “The people are my favourite part of JCSMR!” she enthuses, highlighting the mentorship she received from Professor Leonie Quinn and the collaborative spirit that has fuelled numerous projects.

Dr Teresa Bonello in a hallway at JCSMR.

Dr Teresa Bonello is actively involved in supporting women in the health and medical research sector. Photo: Tracey Nearmy/ANU

This collaborative spirit extends beyond the lab. “Last year, I helped organise the European Molecular Biology Laboratory (EMBL) Australia PhD Course,” Dr Bonello recalls. “It was so rewarding to connect with people across the school and experience how generous my JCSMR colleagues are with their time!”

Recently, Dr Teresa Bonello, alongside Dr Rachel Woodhouse, was awarded the Cancer Council ACT annual grant, a significant milestone in their careers. “During my PhD at the University of New South Wales, I developed new therapeutics to treat neural crest-derived cancers, supported by a three-year Cancer Council Grant,” she explains. This early support was instrumental, and receiving their backing again for a new project is a meaningful continuation of this relationship.

The new project, developed in collaboration with clinical experts at Canberra Hospital, aims to closely align research with patient data. “Working with clinicians to ensure we design the project right has been incredibly constructive, sometimes humbling,” Dr Bonello notes. “My goal is to maintain a bidirectional flow of information between the clinic and our work at the lab bench.”

In addition to her research, Dr Bonello is actively involved in supporting women in the health and medical research sector. “I currently serve in the ACT Peer Advisory Group for Franklin Women, a social enterprise that enables women in the health and medical research sector to thrive,” she says. “I’d love to see more women at JCSMR benefit from the professional development and training opportunities offered by Franklin Women.”

As the ACT State Representative for the Australia and New Zealand Society of Cell and Developmental Biology (ANZSCDB), Dr Bonello is also dedicated to connecting students and early-career researchers with cell and developmental biology research groups at both local and national levels. “I encourage students and ECRs to reach out if they want to better connect with the cell and developmental biology community.”

If you liked this story please follow us on Google News or subscribe to our FacebookInstagram or Twitter accounts.

Related news

Bullet sitting on top of a stethoscope

30 Sep 2024

Attacks on health care during war are becoming more common, creating devastating ripple effects

The head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, has warned attacks on health-care workers, patients and facilities “must not become the norm”.

Euan McNaughton, Associate Professor Katrina Randall and Ainsley Davies.

13 Sep 2024

New Canberra Clinical Phenomics Service to develop advanced diagnostic facility

A federal government grant will help ANU develop a clinical facility dedicated to developing tests for complex diseases.

Related topics

Updated:  22 August 2024/Responsible Officer:  Science Web/Page Contact:  Science Web